ArticlePharmacological research2022

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis.

Wen-Chi Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.